Search research articles
Contact Us
Filters
Showing results (351-360 of 415) with videos related to
Page
of 42
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2026
Prognostic Value of Restaging [<sup>18</sup>F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Therapy
Raghava Kashyap, James P Buteau, Nathan Papa, et al.
BJU International
|
October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells
Laura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
Cristian Udovicich, Mathias Bressel, Jamil Manji, et al.
BJUI Compass
|
April 27, 2022
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management
Nithesh Ranasinha, Altan Omer, Yiannis Philippou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2024
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [<sup>161</sup>Tb]Tb-PSMA-I&T
James P Buteau, Louise Kostos, Ramin Alipour, et al.
World Journal of Urology
|
June 2, 2021
<sup>68</sup>Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial
Patrick Bowden, Andrew W See, Kevin So, et al.
Biological Psychiatry
|
June 22, 2023
Differences in Intrinsic Gray Matter Connectivity and Their Genomic Underpinnings in Autism Spectrum Disorder
Johanna Leyhausen, Tim Schäfer, Caroline Gurr, et al.
Molecular Autism
|
October 4, 2023
The neuroanatomical substrates of autism and ADHD and their link to putative genomic underpinnings
Lisa M Berg, Caroline Gurr, Johanna Leyhausen, et al.
BJU International
|
July 19, 2018
Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017
Edmund Chiong, Declan G Murphy, Hideyuki Akaza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
Page
of 42
Search research articles
Search
Showing results (351-360 of 415) with videos related to
Sort By:
Page
of 42
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2026
Prognostic Value of Restaging [<sup>18</sup>F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Therapy
Raghava Kashyap, James P Buteau, Nathan Papa, et al.
BJU International
|
October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells
Laura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
Cristian Udovicich, Mathias Bressel, Jamil Manji, et al.
BJUI Compass
|
April 27, 2022
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management
Nithesh Ranasinha, Altan Omer, Yiannis Philippou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2024
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [<sup>161</sup>Tb]Tb-PSMA-I&T
James P Buteau, Louise Kostos, Ramin Alipour, et al.
World Journal of Urology
|
June 2, 2021
<sup>68</sup>Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial
Patrick Bowden, Andrew W See, Kevin So, et al.
Biological Psychiatry
|
June 22, 2023
Differences in Intrinsic Gray Matter Connectivity and Their Genomic Underpinnings in Autism Spectrum Disorder
Johanna Leyhausen, Tim Schäfer, Caroline Gurr, et al.
Molecular Autism
|
October 4, 2023
The neuroanatomical substrates of autism and ADHD and their link to putative genomic underpinnings
Lisa M Berg, Caroline Gurr, Johanna Leyhausen, et al.
BJU International
|
July 19, 2018
Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017
Edmund Chiong, Declan G Murphy, Hideyuki Akaza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
Page
of 42